HOFSETH BIOCARE ASA (HBC.OL) Fundamental Analysis & Valuation

OSL:HBC • NO0010598683

Current stock price

1.335 NOK
+0.04 (+3.09%)
Last:

This HBC.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HBC.OL Profitability Analysis

1.1 Basic Checks

  • HBC had negative earnings in the past year.
  • In the past year HBC has reported a negative cash flow from operations.
  • In the past 5 years HBC always reported negative net income.
  • HBC had negative operating cash flow in 4 of the past 5 years.
HBC.OL Yearly Net Income VS EBIT VS OCF VS FCFHBC.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • HBC has a Return On Assets (-34.21%) which is in line with its industry peers.
Industry RankSector Rank
ROA -34.21%
ROE N/A
ROIC N/A
ROA(3y)-32.82%
ROA(5y)-32.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HBC.OL Yearly ROA, ROE, ROICHBC.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • HBC's Gross Margin of 37.19% is in line compared to the rest of the industry. HBC outperforms 44.44% of its industry peers.
  • In the last couple of years the Gross Margin of HBC has grown nicely.
  • The Profit Margin and Operating Margin are not available for HBC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.27%
GM growth 5Y13.53%
HBC.OL Yearly Profit, Operating, Gross MarginsHBC.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. HBC.OL Health Analysis

2.1 Basic Checks

  • HBC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HBC has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for HBC has been increased compared to 5 years ago.
  • HBC has a worse debt/assets ratio than last year.
HBC.OL Yearly Shares OutstandingHBC.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
HBC.OL Yearly Total Debt VS Total AssetsHBC.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of -0.16, we must say that HBC is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -0.16, HBC perfoms like the industry average, outperforming 45.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.16
ROIC/WACCN/A
WACC7.92%
HBC.OL Yearly LT Debt VS Equity VS FCFHBC.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 0.67 indicates that HBC may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.67, HBC is doing worse than 85.19% of the companies in the same industry.
  • HBC has a Quick Ratio of 0.67. This is a bad value and indicates that HBC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.42, HBC is doing worse than 86.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.42
HBC.OL Yearly Current Assets VS Current LiabilitesHBC.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. HBC.OL Growth Analysis

3.1 Past

  • The earnings per share for HBC have decreased by -7.57% in the last year.
  • HBC shows a decrease in Revenue. In the last year, the revenue decreased by -0.42%.
  • HBC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.92% yearly.
EPS 1Y (TTM)-7.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.23%
Revenue 1Y (TTM)-0.42%
Revenue growth 3Y28.63%
Revenue growth 5Y29.92%
Sales Q2Q%11.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HBC.OL Yearly Revenue VS EstimatesHBC.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
HBC.OL Yearly EPS VS EstimatesHBC.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 0.02 0.04 0.06 0.08 0.1

More info and screens

Find the best growth stocksShow best growing peers

0

4. HBC.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HBC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HBC.OL Price Earnings VS Forward Price EarningsHBC.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HBC.OL Per share dataHBC.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HBC.OL Dividend Analysis

5.1 Amount

  • HBC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HBC.OL Fundamentals: All Metrics, Ratios and Statistics

HOFSETH BIOCARE ASA

OSL:HBC (4/22/2026, 9:33:44 AM)

1.335

+0.04 (+3.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners16.62%
Inst Owner ChangeN/A
Ins Owners0.64%
Ins Owner ChangeN/A
Market Cap527.43M
Revenue(TTM)256.34M
Net Income(TTM)-134.88M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.65
BVpS-0.19
TBVpS-0.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -34.21%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.19%
FCFM N/A
ROA(3y)-32.82%
ROA(5y)-32.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.27%
GM growth 5Y13.53%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 51.93%
Cap/Sales 7.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.42
Altman-Z -0.16
F-Score5
WACC7.92%
ROIC/WACCN/A
Cap/Depr(3y)33.59%
Cap/Depr(5y)57.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)14.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.42%
Revenue growth 3Y28.63%
Revenue growth 5Y29.92%
Sales Q2Q%11.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-211.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-143.91%
OCF growth 3YN/A
OCF growth 5YN/A

HOFSETH BIOCARE ASA / HBC.OL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HOFSETH BIOCARE ASA?

ChartMill assigns a fundamental rating of 1 / 10 to HBC.OL.


What is the valuation status for HBC stock?

ChartMill assigns a valuation rating of 0 / 10 to HOFSETH BIOCARE ASA (HBC.OL). This can be considered as Overvalued.


Can you provide the profitability details for HOFSETH BIOCARE ASA?

HOFSETH BIOCARE ASA (HBC.OL) has a profitability rating of 1 / 10.


How sustainable is the dividend of HOFSETH BIOCARE ASA (HBC.OL) stock?

The dividend rating of HOFSETH BIOCARE ASA (HBC.OL) is 0 / 10 and the dividend payout ratio is 0%.